🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There will be 2 phases in this study. Patients will either be enrolled to t...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2006-09
Trial ID
NCT00402116
Treatments Being Tested
The purpose of this study is to find the number of natural killer (NK) cell...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2018-05-22
Trial ID
NCT02890758
Treatments Being Tested
The primary objective of the study is to evaluate the safety and tolerabili...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2018-09-04
Trial ID
NCT04152148
Treatments Being Tested
In Phase I, This study will explore the tolerability and safety of RC118 in...
Status
Recruiting
Location
Zhongshan Hospital Affiliated to Fudan University
Start Date
2022-03-03
Trial ID
NCT05205850
Treatments Being Tested
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
This phase I trial is studying the side effects and best dose of decitabine...
Status
Terminated
Location
Princess Margaret Hospital Phase 2 Consortium
Start Date
2002-09
Trial ID
NCT00049582
Treatments Being Tested
Phase I/II trial to study the effectiveness of BMS-275291 in treating patie...
Status
Completed
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Start Date
2001-08
Trial ID
NCT00024024
Treatments Being Tested
pharmacokinetics/pharmacodynamics of GX-G3 after single subcutaneous admini...
Status
Completed
Location
Chungnam National University Hospital
Start Date
2013-09
Trial ID
NCT01951027
This is a Phase I Clinical Trial to Evaluate the Safety, Tolerability and P...
Status
Unknown
Location
Shanghai East Hospital
Start Date
2022-06-22
Trial ID
NCT05396391
Treatments Being Tested
The purpose of this study is to find the safest and most effective dose for...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2018-04-26
Trial ID
NCT03520504
Treatments Being Tested